Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-κB signaling proteins in colorectal cancer cells

Xiaohua Gao, Dorrah Deeb, Jiang Hao, Yongbo Liu, Ali Syed Arbab, Scott A. Dulchavsky, Subhash C. Gautam

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Lack of apoptotic cell death has been implicated in malignant transformation and resistance to anticancer therapies. The promotion of apoptosis in cancer cells could potentially lead to the regression and improved prognosis of refractory colorectal cancer. Synthetic triterpenoids have shown strong antitumorigenic activity towards diverse cancer cell types, but have not been investigated for colorectal cancer. In the present study, we tested the apoptosis-inducing activity of oleanane triterpenoid 2-cyano-3,12-dioxooleana-1, 9(11)-dien-28-oic acid (CDDO) and its C-28 methyl ester (CDDO-Me) and C-28 imidazole (CDDO-Im) derivatives in colorectal cancer cells lines. Cell growth/viability assay (MTS) demonstrated that colorectal cancer cells are highly sensitive to CDDO-Me at concentrations of 1.25 to 10 μM. The primary mode of tumor cell destruction was apoptosis as demonstrated by the cleavage of PARP-1, activation of procaspases -3, -8, and -9 and mitochondrial depolarization. Induction of apoptosis by CDDO-Me was associated with the inhibition of pro-survival Akt, NF-κB and mTOR signaling proteins and NF-κB-regulated anti-apoptotic Bcl-2, Bcl-xL, Bad and survivin. These studies provide rationale for clinical evaluation of CDDO-Me for the treatment of advanced chemotherapy refractory colorectal cancer.

Original languageEnglish (US)
Pages (from-to)785-792
Number of pages8
JournalAnticancer Research
Volume30
Issue number3
StatePublished - Mar 1 2010
Externally publishedYes

Fingerprint

Colorectal Neoplasms
Apoptosis
Growth
Esters
TOR Serine-Threonine Kinases
Neoplasms
Caspase 8
Caspase 3
Cell Survival
Cell Death
IgA receptor
Drug Therapy
Cell Line
Therapeutics

Keywords

  • Apoptosis
  • Colorectal cancer
  • Signaling proteins
  • Synthetic triterpenoids

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-κB signaling proteins in colorectal cancer cells. / Gao, Xiaohua; Deeb, Dorrah; Hao, Jiang; Liu, Yongbo; Arbab, Ali Syed; Dulchavsky, Scott A.; Gautam, Subhash C.

In: Anticancer Research, Vol. 30, No. 3, 01.03.2010, p. 785-792.

Research output: Contribution to journalArticle

Gao, Xiaohua ; Deeb, Dorrah ; Hao, Jiang ; Liu, Yongbo ; Arbab, Ali Syed ; Dulchavsky, Scott A. ; Gautam, Subhash C. / Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-κB signaling proteins in colorectal cancer cells. In: Anticancer Research. 2010 ; Vol. 30, No. 3. pp. 785-792.
@article{c5592c48224043b182ab3249b3656a54,
title = "Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-κB signaling proteins in colorectal cancer cells",
abstract = "Lack of apoptotic cell death has been implicated in malignant transformation and resistance to anticancer therapies. The promotion of apoptosis in cancer cells could potentially lead to the regression and improved prognosis of refractory colorectal cancer. Synthetic triterpenoids have shown strong antitumorigenic activity towards diverse cancer cell types, but have not been investigated for colorectal cancer. In the present study, we tested the apoptosis-inducing activity of oleanane triterpenoid 2-cyano-3,12-dioxooleana-1, 9(11)-dien-28-oic acid (CDDO) and its C-28 methyl ester (CDDO-Me) and C-28 imidazole (CDDO-Im) derivatives in colorectal cancer cells lines. Cell growth/viability assay (MTS) demonstrated that colorectal cancer cells are highly sensitive to CDDO-Me at concentrations of 1.25 to 10 μM. The primary mode of tumor cell destruction was apoptosis as demonstrated by the cleavage of PARP-1, activation of procaspases -3, -8, and -9 and mitochondrial depolarization. Induction of apoptosis by CDDO-Me was associated with the inhibition of pro-survival Akt, NF-κB and mTOR signaling proteins and NF-κB-regulated anti-apoptotic Bcl-2, Bcl-xL, Bad and survivin. These studies provide rationale for clinical evaluation of CDDO-Me for the treatment of advanced chemotherapy refractory colorectal cancer.",
keywords = "Apoptosis, Colorectal cancer, Signaling proteins, Synthetic triterpenoids",
author = "Xiaohua Gao and Dorrah Deeb and Jiang Hao and Yongbo Liu and Arbab, {Ali Syed} and Dulchavsky, {Scott A.} and Gautam, {Subhash C.}",
year = "2010",
month = "3",
day = "1",
language = "English (US)",
volume = "30",
pages = "785--792",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-κB signaling proteins in colorectal cancer cells

AU - Gao, Xiaohua

AU - Deeb, Dorrah

AU - Hao, Jiang

AU - Liu, Yongbo

AU - Arbab, Ali Syed

AU - Dulchavsky, Scott A.

AU - Gautam, Subhash C.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Lack of apoptotic cell death has been implicated in malignant transformation and resistance to anticancer therapies. The promotion of apoptosis in cancer cells could potentially lead to the regression and improved prognosis of refractory colorectal cancer. Synthetic triterpenoids have shown strong antitumorigenic activity towards diverse cancer cell types, but have not been investigated for colorectal cancer. In the present study, we tested the apoptosis-inducing activity of oleanane triterpenoid 2-cyano-3,12-dioxooleana-1, 9(11)-dien-28-oic acid (CDDO) and its C-28 methyl ester (CDDO-Me) and C-28 imidazole (CDDO-Im) derivatives in colorectal cancer cells lines. Cell growth/viability assay (MTS) demonstrated that colorectal cancer cells are highly sensitive to CDDO-Me at concentrations of 1.25 to 10 μM. The primary mode of tumor cell destruction was apoptosis as demonstrated by the cleavage of PARP-1, activation of procaspases -3, -8, and -9 and mitochondrial depolarization. Induction of apoptosis by CDDO-Me was associated with the inhibition of pro-survival Akt, NF-κB and mTOR signaling proteins and NF-κB-regulated anti-apoptotic Bcl-2, Bcl-xL, Bad and survivin. These studies provide rationale for clinical evaluation of CDDO-Me for the treatment of advanced chemotherapy refractory colorectal cancer.

AB - Lack of apoptotic cell death has been implicated in malignant transformation and resistance to anticancer therapies. The promotion of apoptosis in cancer cells could potentially lead to the regression and improved prognosis of refractory colorectal cancer. Synthetic triterpenoids have shown strong antitumorigenic activity towards diverse cancer cell types, but have not been investigated for colorectal cancer. In the present study, we tested the apoptosis-inducing activity of oleanane triterpenoid 2-cyano-3,12-dioxooleana-1, 9(11)-dien-28-oic acid (CDDO) and its C-28 methyl ester (CDDO-Me) and C-28 imidazole (CDDO-Im) derivatives in colorectal cancer cells lines. Cell growth/viability assay (MTS) demonstrated that colorectal cancer cells are highly sensitive to CDDO-Me at concentrations of 1.25 to 10 μM. The primary mode of tumor cell destruction was apoptosis as demonstrated by the cleavage of PARP-1, activation of procaspases -3, -8, and -9 and mitochondrial depolarization. Induction of apoptosis by CDDO-Me was associated with the inhibition of pro-survival Akt, NF-κB and mTOR signaling proteins and NF-κB-regulated anti-apoptotic Bcl-2, Bcl-xL, Bad and survivin. These studies provide rationale for clinical evaluation of CDDO-Me for the treatment of advanced chemotherapy refractory colorectal cancer.

KW - Apoptosis

KW - Colorectal cancer

KW - Signaling proteins

KW - Synthetic triterpenoids

UR - http://www.scopus.com/inward/record.url?scp=77951039020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951039020&partnerID=8YFLogxK

M3 - Article

C2 - 20392997

AN - SCOPUS:77951039020

VL - 30

SP - 785

EP - 792

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -